A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (Q3019496): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
ReferenceBot (talk | contribs) Changed an Item |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1080/02664763.2010.505955 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2028645887 / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank | |||
Normal rank | |||
| Property / cites work | |||
| Property / cites work: Design and Analysis of Phase I Clinical Trials / rank | |||
Normal rank | |||
Latest revision as of 08:04, 4 July 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches |
scientific article |
Statements
A class of designs for Phase I cancer clinical trials combining Bayesian and likelihood approaches (English)
0 references
28 July 2011
0 references
dose escalation
0 references
MTD
0 references
Bayesian
0 references
maximum likelihood
0 references
0 references
0 references
